BPMC
Price
$86.70
Change
-$0.42 (-0.48%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
5.57B
51 days until earnings call
TARS
Price
$44.59
Change
-$1.88 (-4.05%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
1.71B
63 days until earnings call
Ad is loading...

BPMC vs TARS

Header iconBPMC vs TARS Comparison
Open Charts BPMC vs TARSBanner chart's image
Blueprint Medicines
Price$86.70
Change-$0.42 (-0.48%)
Volume$13.89K
Capitalization5.57B
Tarsus Pharmaceuticals
Price$44.59
Change-$1.88 (-4.05%)
Volume$11K
Capitalization1.71B
BPMC vs TARS Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. TARS commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a StrongBuy and TARS is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (BPMC: $87.12 vs. TARS: $46.47)
Brand notoriety: BPMC and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 89% vs. TARS: 95%
Market capitalization -- BPMC: $5.57B vs. TARS: $1.71B
BPMC [@Biotechnology] is valued at $5.57B. TARS’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileTARS’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • TARS’s FA Score: 0 green, 5 red.
According to our system of comparison, TARS is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 4 TA indicator(s) are bullish while TARS’s TA Score has 4 bullish TA indicator(s).

  • BPMC’s TA Score: 4 bullish, 5 bearish.
  • TARS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BPMC is a better buy in the short-term than TARS.

Price Growth

BPMC (@Biotechnology) experienced а -9.79% price change this week, while TARS (@Biotechnology) price change was +4.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

BPMC is expected to report earnings on May 01, 2025.

TARS is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($5.57B) has a higher market cap than TARS($1.71B). BPMC YTD gains are higher at: -0.115 vs. TARS (-16.074). BPMC has higher annual earnings (EBITDA): -75.58M vs. TARS (-126.97M). BPMC has more cash in the bank: 734M vs. TARS (317M). TARS has less debt than BPMC: TARS (72.3M) vs BPMC (471M). BPMC has higher revenues than TARS: BPMC (434M) vs TARS (130M).
BPMCTARSBPMC / TARS
Capitalization5.57B1.71B325%
EBITDA-75.58M-126.97M60%
Gain YTD-0.115-16.0741%
P/E RatioN/AN/A-
Revenue434M130M334%
Total Cash734M317M232%
Total Debt471M72.3M651%
FUNDAMENTALS RATINGS
BPMC: Fundamental Ratings
BPMC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
70
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
58
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BPMCTARS
RSI
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
73%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 14 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FWD75.440.20
+0.27%
AB Disruptors ETF
SPCX23.710.03
+0.11%
SPAC and New Issue ETF
HYFI37.170.03
+0.08%
AB High Yield ETF
JPIE45.950.01
+0.02%
JPMorgan Income ETF
FDCF38.31-0.04
-0.10%
Fidelity Disruptive Communications ETF

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with DNLI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-1.60%
DNLI - BPMC
43%
Loosely correlated
+2.58%
ORIC - BPMC
42%
Loosely correlated
+1.91%
AXON - BPMC
41%
Loosely correlated
+5.43%
TECH - BPMC
41%
Loosely correlated
+1.55%
ARWR - BPMC
39%
Loosely correlated
-3.96%
More

TARS and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARS has been loosely correlated with ADMA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then ADMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARS
1D Price
Change %
TARS100%
+6.66%
ADMA - TARS
39%
Loosely correlated
+0.65%
RYTM - TARS
36%
Loosely correlated
-1.65%
CRNX - TARS
34%
Loosely correlated
-2.43%
JANX - TARS
33%
Loosely correlated
-0.36%
IDYA - TARS
32%
Poorly correlated
-3.20%
More